US FDA

(21 search results)

Gujarat’s ₹25,000 stent shocker: U.S. FDA-approved devices get double the price of Indian ones
Parliament panel slams drug regulator CDSCO for delays, calls for overhaul of medical device licensing
Sun Pharma to acquire Checkpoint Therapeutics for $355 million
Lupin gets US FDA report for Pithampur unit; shares jump 2%
Aurobindo Pharma shares rise 2% on USFDA nod for nasal spray
From ₹397 to ₹1,081: This largecap pharma stock surges 170% in 10 months
Lupin shares rise 2% on launching heart drug in Canada
US FDA flags ‘significant violations’ of CGMP norms at Gujarat-based Intas Pharma
Lupin hits 52-week high on US FDA nod for respiratory drug
Cough syrup row: Sample testing at designated labs now must for exporters
U.S. FDA issues warning letter to Intas Pharma over manufacturing lapses